Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 11/20 | 0.41 |
| ▸ | AXL | P30530 | 10/20 | 0.41 |
| ▸ | BTK | Q06187 | 7/20 | 0.39 |
| ▸ | EGFR | P00533 | 4/20 | 0.38 |
| ▸ | LCK | P06239 | 3/20 | 0.37 |
| ▸ | ITK | Q08881 | 2/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18045206 | 1.00 | MET (0.41) | METAXLBTKEGFRLCK | |
| SCHEMBL18044743 | 0.85 | MET (0.46) | METAXLEGFRFLT3 | |
| SCHEMBL18044739 | 0.85 | MET (0.42) | METAXLBTKEGFRFLT3 | |
| SCHEMBL18045189 | 0.84 | MET (0.41) | METAXLEGFRFLT3 | |
| SCHEMBL16709399 | 0.76 | MET (0.51) | METAXLEGFRFLT3 | |
| SCHEMBL18044747 | 0.76 | MET (0.57) | METAXLEGFRFLT3 | |
| SCHEMBL18044586 | 0.76 | AXL (0.50) | METAXLEGFRFLT3 | |
| SCHEMBL18044658 | 0.75 | MET (0.44) | METAXLEGFRFLT3 | |
| SCHEMBL18044585 | 0.74 | MET (0.43) | METAXLEGFRFLT3 | |
| SCHEMBL18044591 | 0.74 | ALDH1A1 (0.56) | METAXLFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9586967-B2 | Pyrrolo pyrimidine derivative | ONO PHARMACEUTICAL CO., LTD. (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20160264579-A1 | PYRROLO PYRIMIDINE DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264579-A1 | PYRROLO PYRIMIDINE DERIVATIVE | AXL, FLT3, TYRO3 | MET 398/4885AXL 1/4885BTK 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.